在差分化甲状腺癌的预测因素和临床病理学特征:一个单一机构研究的研究结果
Zheng Wan1, Bing Wang1, Jing Yao1
1Department of Thyroid & Hernia Surgery, Medical Department of General Surgery, Chinese People's Liberation Army General Hospital, Beijing, China.
Frontiers in oncology
|July 24, 2023
概括
这项研究确定了影响差异化甲状腺癌生存的关键因素. 诊断时的年龄,甲状腺外延伸和相关的甲状腺癌影响无复发生存率,而整体死亡率与年龄,性别和治疗因素有关.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 差分化甲状腺癌 (PDTC) 是一个重大的临床挑战.
- 了解其临床病理学特征对于改善患者的治疗结果至关重要.
研究的目的:
- 阐明PDTC的临床病理特征.
- 确定PDTC患者整体和无复发生存的独立预后因素.
主要方法:
- 在2005年至2020年期间诊断的94名PDTC患者的回顾性审查.
- 收集和分析临床和病理学数据.
- 用单变量和多变量考克斯回归分析来确定预后因素.
主要成果:
- 没有复发的死亡率与诊断时的年龄,甲状腺外延伸和相关的甲状腺癌相关 (p<0.05).
- 总的死亡率与诊断时的年龄,性别,甲状腺外延伸,T阶段 (AJCC第八),手术和辐射 (p<0.05) 显著相关.
- 平均总生存时间为33个月,平均无复发生存时间为14个月.
结论:
- 中年和老年患者仍然面临PDTC的高风险.
- 由于PDTC的病理结果多样化,因此需要量身定制的治疗策略,以获得最佳的预后.
相关概念视频
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer Survival Analysis
390
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
390


